• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Consumer Cyclical·HLF
Held by 4 Gurus
Share

Herbalife Ltd. Stocks

$ 13.03Last Updated 09.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Moderate

Recommendation

Hold

Market Cap

$ 1.33B

$ 13.03
Key Takeaways

Risk factor

High price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Seth Klarman

Portfolio Weight (%)

2.3%

Change

-0.41%

Fund

Baupost Group

Bob Prince, Greg Jensen, Karen Karniol-Tambour

Portfolio Weight (%)

0.0%

Change

-0.01%

Fund

Bridgewater Associates

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Seth KlarmanBaupost Group2.3%-0.41%
Bob Prince, Greg Jensen, Karen Karniol-TambourBridgewater Associates0.0%-0.01%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%
Show more

Latest news

08.10.2026 17:54

Short Selling: How Carl Icahn Lost $22 Billion Betting Against the Market

10.04.2026 17:01

10 'strong buy' small caps worth watching amid AI progress, rotation out of mega caps

17.02.2026 09:00

Amazon, Google and Herbalife: billionaire Seth Klarman revealed last quarter's deals

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Herbalife Nutrition Ltd. is a global enterprise dedicated to providing comprehensive nutritional solutions. Its market presence extends across various international regions, including North America, Mexico, Central and South America, Europe, the Middle East, Africa, China, and the broader Asia Pacific area. The company’s extensive product catalog caters to several core wellness categories, encompassing weight management, specialized nutritional supplementation, energy and athletic performance, and external personal care. Specifically, its weight management offerings feature items like meal replacements, protein shakes, powdered drink mixes, weight loss aids, and healthy snacks. For targeted nutrition, Herbalife provides functional beverages alongside dietary and nutritional supplements rich in herbs, vitamins, minerals, and other naturally derived ingredients. The outer nutrition range includes products for facial, body, and hair care, while its energy, sports, and fitness segment includes popular items such as N-R-G tea and various energy drinks. In addition to its product lines, Herbalife furnishes supporting materials, which comprise start-up kits, sales tools, informational literature, and educational resources. The company employs a multi-channel distribution strategy, primarily leveraging independent service providers and sales representatives, alongside its own company-operated retail platforms. Founded in Los Angeles, California, in 1980, the organization was known as Herbalife Ltd. until April 2018, when it officially rebranded to Herbalife Nutrition Ltd.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBITDA, undervalue

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of HLF is 17.3 and suggests 33.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

10.10.2026 16:01

What's Important in Small-Cap Stocks: Risks Associated with Webull, Levi's Outlook, and Vaxcyte's Success

10.10.2026 13:01

How soon will the AI bubble burst? Will France infect the Eurozone? What's wrong with Levi's jeans?

10.10.2026 06:47

Moderna hits four-year high as NYT reports U.S. cancer vaccine effort

10.10.2026 04:58

Palantir shares hit a new high: Barclays followed Goldman in recommending a buy

10.10.2026 04:25

Apple has cut orders for parts for the new iPhones, according to media reports. Was demand lower than expected?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026